Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel

Clin Microbiol Infect. 2013 Aug;19(8):752-6. doi: 10.1111/1469-0691.12004. Epub 2012 Sep 25.

Abstract

The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiary-care and 12 community hospitals). The study included 444 episodes of candidaemia (450 patient-specific isolates, 8.5% fluconazole-resistant). Institutional FRC bloodstream infection rates correlated with annual inpatient days, and were strongly associated with the presence and activity of haematology/oncology services. Infection with Candida krusei and fluconazole-resistant Candida glabrata occurred exclusively in hospitals with >600 beds. These findings suggest that empirical antifungal strategies should be tailored to the nosocomial setting.

Keywords: Candidaemia; drug resistance; epidemiology; fluconazole.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antifungal Agents / pharmacology*
  • Candida / drug effects*
  • Candida / isolation & purification
  • Candida glabrata
  • Candidemia / epidemiology*
  • Cross Infection / epidemiology*
  • Drug Resistance, Fungal*
  • Female
  • Fluconazole / pharmacology*
  • Hospitals
  • Humans
  • Israel / epidemiology
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies

Substances

  • Antifungal Agents
  • Fluconazole